Idiopathic Hypersomnia (IH) Treatment Market
Idiopathic Hypersomnia (IH) Treatment Market - Global Industry Assessment & Forecast
#
Pages:
212
Base Year:
2023
Dec - 2024
Format:
Report Code:
VMR-3863
Segments Covered
By
Drug Class Stimulant Medications, Non-stimulant wake-promoting Medications, Sodium Oxybate
-
By
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 340.4 Million |
 Revenue 2032:
|
USD 835.2 Million |
 Revenue CAGR
(2024 - 2032): |
8.5% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Idiopathic Hypersomnia (IH) Treatment Market Segment Analysis
- Idiopathic Hypersomnia (IH) Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Idiopathic Hypersomnia (IH) Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
-
North America Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S.
- U.S. Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- U.S. Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S. Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Canada
- Canada Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Canada Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Canada Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Mexico
- Mexico Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Mexico Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Mexico Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
North America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Europe
-
Europe Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
-
Europe Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U. K.
- U.K. Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- U.K. Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.K. Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- France
- France Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- France Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- France Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Germany
- Germany Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Germany Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Italy
- Italy Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Italy Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Italy Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Spain
- Spain Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Spain Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Spain Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Rest of Europe
- Rest of Europe Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Rest of Europe Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Europe Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Europe Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Asia Pacific
-
Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
-
Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China
- China Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- China Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Japan
- Japan Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Japan Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Japan Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Germany
- Germany Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Germany Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
India
- India Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- India Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- India Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
South Korea
- South Korea Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- South Korea Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Korea Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
South East Asia
- South East Asia Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- South East Asia Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South East Asia Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Rest of Asia Pacific
- Rest of Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Rest of Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Latin America
-
Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
-
Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil
- Brazil Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Brazil Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Argentina
- Argentina Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Argentina Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Argentina Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Rest of Latin America
- Rest of Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Rest of Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Middle East & Africa
-
Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
-
Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries
- GCC Countries Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- GCC Countries Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- South Africa
- South Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- South Africa Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- Stimulant Medications
- Non-stimulant wake-promoting Medications
- Sodium Oxybate
- Rest of Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
-
Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
- North America
Vantage Market
Research | 03-Jan-2025
FAQ
Frequently Asked Question
What is the global demand for Idiopathic Hypersomnia (IH) Treatment in terms of revenue?
-
The global Idiopathic Hypersomnia (IH) Treatment valued at USD 340.4 Million in 2023 and is expected to reach USD 835.2 Million in 2032 growing at a CAGR of 8.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Merck & Co. Inc.,Jazz Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd.,BIOPROJET, Avadel Pharmaceuticals, PIc. GlaxoSmithKline plc, Pfizer Inc. Theranexus, Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.5% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Idiopathic Hypersomnia (IH) Treatment include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Idiopathic Hypersomnia (IH) Treatment in 2023.
